Ranitidine Injection is an H2 receptor antagonist used to reduce stomach acid production, prevent and treat ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome in hospital settings.
Brand Name: RANITIDINE
Generic Name: Ranitidine Hydrochloride Injection BP
Available Strengths:
Ranitidine Injection 25mg/ 50mg
Ranitidine Injection is a widely used H2 receptor antagonist that effectively reduces gastric acid secretion, providing relief in conditions like peptic ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. Administered intravenously under medical supervision, it is commonly used in hospital and emergency settings where rapid acid suppression is required. By inhibiting histamine action on gastric parietal cells, Ranitidine Injection helps heal ulcers, prevent gastrointestinal bleeding, and manage acid-related complications. Its fast onset of action and reliable efficacy make it an essential medicine in critical care, surgical procedures, and patients unable to take oral medications.
Capabilities Offered:
Ready dossier for both strengths in CTD/ ACTD format
Third party manufacturing services
Contract Manufacturing (CMO Services)
Formulation Development Services
Regulatory & Documentation Support
Export / Licensing Services
In addition to the products listed on our website, we possess the technical capability and infrastructure to develop and manufacture customized formulations as per your specific requirements and regulatory markets.
For business inquiries, email at sales@cooperpharma.com
